Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DVLT NYSE:IBM NASDAQ:NMHI NASDAQ:SCLX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDVLTDatavault AI$0.44-2.8%$0.66$0.25▼$4.10$306.70M0.3459.59 million shs58.10 million shsIBMInternational Business Machines$224.71+1.1%$239.09$212.34▼$324.90$211.20B0.585.97 million shs4.86 million shsNMHINature's Miracle$0.00-20.0%$0.00$0.00▼$0.46$485K0.1419.93 million shs147.25 million shsSCLXScilex$6.01+0.5%$7.34$4.20▼$34.27$51.03M1.7762,458 shs47,577 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDVLTDatavault AI-9.60%-19.11%-40.37%-39.45%-56.12%IBMInternational Business Machines-0.24%+1.20%-12.31%-14.81%-17.15%NMHINature's Miracle-9.09%+66.67%+25.00%-85.92%-98.88%SCLXScilex0.00%-12.19%-13.33%-27.25%+27.23%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDVLTDatavault AI$0.44-2.8%$0.66$0.25▼$4.10$306.70M0.3459.59 million shs58.10 million shsIBMInternational Business Machines$224.71+1.1%$239.09$212.34▼$324.90$211.20B0.585.97 million shs4.86 million shsNMHINature's Miracle$0.00-20.0%$0.00$0.00▼$0.46$485K0.1419.93 million shs147.25 million shsSCLXScilex$6.01+0.5%$7.34$4.20▼$34.27$51.03M1.7762,458 shs47,577 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDVLTDatavault AI-9.60%-19.11%-40.37%-39.45%-56.12%IBMInternational Business Machines-0.24%+1.20%-12.31%-14.81%-17.15%NMHINature's Miracle-9.09%+66.67%+25.00%-85.92%-98.88%SCLXScilex0.00%-12.19%-13.33%-27.25%+27.23%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDVLTDatavault AI 2.00Hold$3.00583.22% UpsideIBMInternational Business Machines 2.70Moderate Buy$294.4131.02% UpsideNMHINature's Miracle 0.00N/AN/AN/ASCLXScilex 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest SCLX, NMHI, IBM, and DVLT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2026IBMInternational Business Machines Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$330.00 ➝ $300.005/6/2026IBMInternational Business Machines WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$320.005/4/2026IBMInternational Business Machines Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B) ➝ Buy (B-)4/28/2026IBMInternational Business Machines HSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeReduce ➝ Hold$218.00 ➝ $231.004/24/2026DVLTDatavault AI Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/24/2026IBMInternational Business Machines DZ BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$295.004/23/2026IBMInternational Business Machines WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$340.00 ➝ $320.004/23/2026IBMInternational Business Machines BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Perform$290.00 ➝ $270.004/23/2026IBMInternational Business Machines Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$215.00 ➝ $225.004/21/2026IBMInternational Business Machines Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy (B)4/20/2026IBMInternational Business Machines Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$370.00 ➝ $320.00(Data available from 5/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDVLTDatavault AI$41.88M7.32N/AN/A$0.32 per share1.37IBMInternational Business Machines$68.91B3.06$17.29 per share13.00$35.17 per share6.39NMHINature's Miracle$9.99M0.05N/AN/A($9.06) per share0.00SCLXScilex$30.25M1.69N/AN/A($24.94) per share-0.24Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDVLTDatavault AI-$78.99M-$0.92N/AN/AN/A-292.68%-64.71%-52.12%N/AIBMInternational Business Machines$10.59B$11.3119.8716.822.3115.61%37.23%7.49%7/22/2026 (Estimated)NMHINature's Miracle-$7.34M-$0.91N/AN/AN/A-127.93%N/A-95.86%N/ASCLXScilex-$358.73M-$36.45N/AN/AN/A-1,185.78%N/A-178.57%6/3/2026 (Estimated)Latest SCLX, NMHI, IBM, and DVLT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/3/2026N/ASCLXScilex-$0.3373N/AN/AN/A$15.00 millionN/A5/20/2026Q1 2026SCLXScilexN/A-$6.28N/A-$6.28N/A$8.61 million4/22/2026Q1 2026IBMInternational Business Machines$1.81$1.91+$0.10$1.28$15.60 billion$15.92 billion4/10/2026Q4 2025SCLXScilex-$0.47-$4.60-$4.13-$4.60$12.10 million$4.79 million3/18/2026Q4 2025DVLTDatavault AIN/A$0.53N/A$0.53N/A$33.82 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDVLTDatavault AIN/AN/AN/AN/AN/AIBMInternational Business Machines$6.763.01%+0.61%59.77%30 YearsNMHINature's MiracleN/AN/AN/AN/AN/ASCLXScilexN/AN/AN/AN/AN/ALatest SCLX, NMHI, IBM, and DVLT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/22/2026IBMInternational Business Machinesquarterly$1.692.95%5/8/20265/8/20266/10/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDVLTDatavault AI0.024.625.29IBMInternational Business Machines1.750.800.76NMHINature's MiracleN/A0.410.24SCLXScilexN/A0.080.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDVLTDatavault AI0.66%IBMInternational Business Machines58.96%NMHINature's Miracle94.56%SCLXScilex69.67%Insider OwnershipCompanyInsider OwnershipDVLTDatavault AI7.70%IBMInternational Business Machines0.27%NMHINature's Miracle6.50%SCLXScilex4.11%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDVLTDatavault AI40698.47 million644.69 millionN/AIBMInternational Business Machines286,800939.89 million937.35 millionOptionableNMHINature's Miracle12606.63 million1.07 millionN/ASCLXScilex808.49 million8.14 millionNo DataSCLX, NMHI, IBM, and DVLT HeadlinesRecent News About These CompaniesScilex Delays Quarterly Report Amid Consolidation WorkMay 15, 2026 | tipranks.comScilex Announces Special Dream Bowl Token DividendMay 11, 2026 | tipranks.comPHOE stock more than doubles on strategic pivot into pharma industry with Scilex dealMay 5, 2026 | msn.comScilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings LimitedMay 5, 2026 | theglobeandmail.comScilex Subsidiary Reshapes Phoenix Asia via $1B Share DealMay 5, 2026 | tipranks.comScilex Holding Company Announces Acquisition Agreement Between ACEA Therapeutics and Phoenix Asia HoldingsMay 5, 2026 | quiverquant.comQScilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to ...May 4, 2026 | markets.businessinsider.comScilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of April 30, 2026May 4, 2026 | globenewswire.comScilex (NASDAQ:SCLX) Downgraded to "Strong Sell" Rating by Wall Street ZenMay 2, 2026 | marketbeat.comShort Interest in Scilex Holding Company (NASDAQ:SCLX) Decreases By 15.4%May 1, 2026 | marketbeat.comScilex Plans Major Investment in Datavault Quantum-Ready NetworkApril 28, 2026 | tipranks.comDatavault AI (NASDAQ: DVLT) Executes $120M Term Sheet With Scilex for Quantum-Ready Edge Network DeploymentApril 27, 2026 | usatoday.comDatavault AI Announces Execution of Binding Term Sheet for $120 Million Cash Contribution From Scilex Holding Company to Fund 100-City GPU Expansion of Quantum-Ready SanQtum PlatformApril 27, 2026 | businesswire.comScilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026April 20, 2026 | globenewswire.comScilex Delays 2025 Annual 10-K FilingApril 1, 2026 | tipranks.comScilex Files Federal Lawsuit Over Misappropriated Datavault CollateralMarch 13, 2026 | tipranks.comScilex Holding Company Files Complaint Over Alleged Unauthorized Sale of $100 Million in Pledged SharesMarch 13, 2026 | quiverquant.comQScilex Holding Company Files Federal Securities Fraud Lawsuit Seeking Recovery of Approximately Ninety-Six (96) Million Misappropriated Collateral Shares of Datavault AI, Inc. from Marc Wade, The St. James Bank & Trust Company Ltd., Omega & Corinth Group Ltd.March 13, 2026 | globenewswire.comScilex Files Securities Fraud Suit Over Stock LoanMarch 13, 2026 | tipranks.comScilex Grants Oramed New Warrant in Financing AgreementFebruary 20, 2026 | tipranks.comDatavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 2026February 5, 2026 | accessnewswire.comANew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe Real SpaceX Play: 5 Chip Stocks Powering the IPO Before It LaunchesBy Bridget Bennett | May 4, 2026AMD’s Breakout Isn’t the Story—This Catalyst IsBy Thomas Hughes | April 24, 2026Apple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 2026Datavault Gains Traction: 5 Reasons to Sell NowBy Thomas Hughes | May 15, 2026Catching Falling Knives: Is It Time to Buy These Beaten-Down Stocks?By Dan Schmidt | May 11, 2026SCLX, NMHI, IBM, and DVLT Company DescriptionsDatavault AI NASDAQ:DVLT$0.44 -0.01 (-2.77%) Closing price 04:00 PM EasternExtended Trading$0.44 0.00 (-0.02%) As of 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Datavault AI Inc., a data sciences technology company, owns and operates data management and supercomputer platforms. It offers data technology and software solutions. The company was formerly known as WiSA Technologies, Inc. and changed its name to Datavault AI Inc. in February 2025. Datavault AI Inc. was incorporated in 2010 and is headquartered in Beaverton, Oregon.International Business Machines NYSE:IBM$224.71 +2.38 (+1.07%) Closing price 03:59 PM EasternExtended Trading$224.05 -0.66 (-0.29%) As of 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide. The company operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers a hybrid cloud and AI platforms that allows clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment focuses on skills integration for strategy, experience, technology, and operations by domain and industry. The Infrastructure segment provides on-premises and cloud based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. The Financing segment offers client and commercial financing, facilitates IBM clients' acquisition of hardware, software, and services. The company has a strategic partnership to various companies including hyperscalers, service providers, global system integrators, and software and hardware vendors that includes Adobe, Amazon Web services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.Nature's Miracle NASDAQ:NMHI$0.0008 0.00 (-20.00%) As of 03:57 PM EasternNature's Miracle Holding Inc., an agriculture technology company, provides lighting and grow media products to growers in the controlled environment agriculture industry in the United States and Canada. The company offers LED fixtures; high pressure sodium and ceramic metal halide fixtures; and electronic ballasts and control boxes. It also designs, builds, and operates various indoor growing settings, including greenhouse and indoor-growing spaces. The company sells its products directly to wholesale CEA distributors. Nature's Miracle Holding Inc. is headquartered in Ontario, California.Scilex NASDAQ:SCLX$6.01 +0.03 (+0.50%) Closing price 04:00 PM EasternExtended Trading$6.17 +0.16 (+2.66%) As of 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company is also developing three product candidates, including SP-102 (10 mg dexamethasone sodium phosphate viscous gel) (SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a Phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4% (SP-103), a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a Phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules) (SP-104), a novel low-dose delayed-release naltrexone hydrochloride, which has completed Phase 1 trials for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook AI Consolidation Begins: Blackstone & Google Forge an AI Empire The Great AI Rotation: Cashing In on Data Mirum Pharma: A Rare Disease Growth Story to Watch Vertical Aerospace: Pre-Flight Checks Point to a Breakout HIVE Weaponizes Power for an AI Pivot Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
